Recognition of ischemic heart disease (IHD) is often delayed or deferred in women. Thus,
many at risk for adverse outcomes are not provided specific diagnostic, preventive, and/or …

Objectives : The purpose of this study was to estimate rates and identify predictors of
inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for …

Objectives : The objective of this study was to determine the cost-effectiveness and cost per
quality-adjusted life year (QALY) gained of sacubitril-valsartan relative to enalapril for …

Background : Many patients with acute myocardial infarction (AMI) and cardiogenic shock
survive hospitalization; little is known about their subsequent prognosis. Objectives : This …

Background: The choice of antiplatelet therapy after acute coronary syndrome (ACS) is
complicated: Ticagrelor and prasugrel are novel alternatives to clopidogrel, patients with some …

Background Little is known about the relationship between ejection fraction (EF) and clinical
outcomes among older patients with myocardial infarction in contemporary clinical practice. …

Objectives : The aim of this study was to quantify changes in percutaneous coronary intervention
(PCI) and mortality rates for ST-segment elevation myocardial infarction (STEMI), and …

Background— The very elderly (age 80 years and older) with heart failure (HF) is a growing
population that is rarely included in clinical trials. The aim of this investigation was to …

Acquired cardiovascular conditions are a leading cause of maternal morbidity and mortality.
A growing number of pregnant women have acquired and heritable cardiovascular …

Background PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors effectively lower
LDL (low‐density lipoprotein) cholesterol and have been shown to reduce cardiovascular …